abstract
Future of Health Summit 2023

No Turning Back: Protecting the Progress for Biomedical Innovation

-

The COVID-19 pandemic forced remarkable collaboration and acceleration in biomedical R&D. While much of the national and international response was far from optimal, we showed ourselves capable of actions previously thought impossible. As the sense of urgency felt at the height of COVID subsides, how can we ensure that the capacity for innovation is not lost? Can the same urgency demonstrated during the pandemic be harnessed to combat not just future disease outbreaks but all aspects of biomedical R&D? Without sacrificing safety, what incentives are needed to streamline the collaboration and processes to enable more rapid cures? Can we sustain the focus on health equity engendered in recent years?

    Moderator

    Image

    Rick Berke

    Co-Founder and Executive Editor, STAT

    Speakers

    Image

    Amy Abernethy

    President, Product Development and Chief Medical Officer, Verily
    Image

    Christopher Austin

    CEO-Partner, Flagship Pioneering; CEO, Vesalius Therapeutics
    Image

    Yvonne Sprow

    Senior Vice President, Global Communications, Novavax
    Image

    Janet Woodcock

    Principal Deputy Commissioner, Food and Drug Administration